Dramatic changes in glycolipid metabolism associated with oncogenic transformation implicate a specific role for membrane glycolipids in regulation of cell growth and cellular recognition. These changes give rise to tumor specific membrane antigens which are useful diagnostically and as potential targets for immunotherapy. Although many examples of these tumor antigens have been documented, not much information is available relating to the mechanism of regulation of biosynthesis which prevents expression of these carbohydrate structures in normal cells and tissues and is activated to produce them in association with oncogenesis. A variety of lacto-series based carbohydrate antigens have been described to occur inhuman colonic adenocarcinomas. Recent evidence has shown that activation of a normally unexpressed beta1-leads to 3N- acetylglucosaminyltransferase required for lacto-series chain synthesis occurs in colonic epithelial cells and results in accumulation of these antigens. This application proposes to extend these observations to study in detail interactions of other enzyme activities associated with the synthesis of a variety of end-stage structures which occur in these tumors. The beta1-3N-acetylglucosaminyltransferase which is activated is association with oncogenesis will be extensively studied. This enzyme will be purified to homogeneity from a soluble enzyme source such as serum or milk, antibodies prepared against it, and this enzyme studied in terms of its physical properties. N- terminal sequence data will be obtained which, along with specific antibodies, will form a basis for future studies relating to isolation of genetic information which encodes the enzyme. This will then lead to studies of the regulation of gene expression during both development and oncogenesis. Coupled with this will be studies of the basis for relative synthesis of type 1 or 2 chain structures in normal mucosa and adenocarcinoma tumors. The beta1 leads to 3 galactosyltransferase associated with type 1 chain synthesis will also be studied extensively as an isolated protein and in terms of membrane interactions with other components in order to gain information on the detailed basis for almost exclusive synthesis of type 1 chain structures in normal mucosa as compared to tumors which contain a high proportion of type 2 chain based structures.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA041521-04
Application #
3182086
Study Section
Pathology B Study Section (PTHB)
Project Start
1986-01-07
Project End
1991-12-31
Budget Start
1989-01-01
Budget End
1989-12-31
Support Year
4
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Pacific Northwest Research Institute
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98122
Amado, M; Almeida, R; Carneiro, F et al. (1998) A family of human beta3-galactosyltransferases. Characterization of four members of a UDP-galactose:beta-N-acetyl-glucosamine/beta-nacetyl-galactosamine beta-1,3-galactosyltransferase family. J Biol Chem 273:12770-8
Schwientek, T; Almeida, R; Levery, S B et al. (1998) Cloning of a novel member of the UDP-galactose:beta-N-acetylglucosamine beta1,4-galactosyltransferase family, beta4Gal-T4, involved in glycosphingolipid biosynthesis. J Biol Chem 273:29331-40
Holmes, E H; Xu, Z; Sherwood, A L et al. (1995) Structure-function analysis of human alpha 1-->3fucosyltransferases. A GDP-fucose-protected, N-ethylmaleimide-sensitive site in FucT-III and FucT-V corresponds to Ser178 in FucT-IV. J Biol Chem 270:8145-51
Hu, J; Stults, C L; Holmes, E H et al. (1994) Structural characterization of intermediates in the biosynthetic pathway of neolacto glycosphingolipids: differential expression in human leukaemia cells. Glycobiology 4:251-7
Meldgaard, P; Holmes, E H; Bennett, E P et al. (1994) Blood group ABO-related glycosylation of urothelial cell lines: immunocytological, enzymatic, and genetic characterization. Cancer Res 54:2440-7
Holmes, E H; Macher, B A (1993) Specificity of fucose transfer to GlcNAc residues of extended chain neolacto-series glycolipids catalyzed by human alpha 1-->3fucosyltransferases: effect of the lipidic environment on the myeloid enzyme form. Arch Biochem Biophys 301:190-9
Holmes, E H (1993) Human Lewis alpha 1-->3/4fucosyltransferase: specificity of fucose transfer to GlcNAc beta 1-->3Gal beta 1-->4Glc beta 1-->1Cer (LcOse3Cer). Glycobiology 3:77-81
Holmes, E H; Greene, T G (1993) De novo synthesis of type 1 lacto-series glycolipids in human colonic adenocarcinoma cells: efficient synthesis of the Le(a) antigen and absence of brefeldin A-induced inhibition of its synthesis in Colo 205 cells. Arch Biochem Biophys 305:328-40
Symington, F W; Holmes, E H; Symington, B E (1992) Human epidermal keratinocyte expression of sialyl-Lewis X. J Invest Dermatol 99:601-7
Sherwood, A L; Greene, T G; Holmes, E H (1992) Stable expression of a cDNA encoding a human beta 1 --> 3galactosyltransferase responsible for lacto-series type 1 core chain synthesis in non-expressing cells: variation in the nature of cell surface antigens expressed. J Cell Biochem 50:165-77

Showing the most recent 10 out of 26 publications